Ads

 

Ads

 

Ads

 

Karyopharm Therapeutics

Karyopharm Therapeutics

World Rank (Jan-05-2024)
21,647
Market Cap (Jan-05-2024)
0.096 Billion USD
World Rank (Jul-30-2023)
17,908
Market Cap (Jul-30-2023)
0.205 Billion USD
World Rank (Jan-07-2022)
13,136
Market Cap (Jan-07-2022)
0.533 Billion USD
World Rank (Jan-01-2021)
7,510
Market Cap (Jan-01-2021)
1.119 Billion USD
Headquarters Country
Nasdaq / NYSE Code
KPTI
Market Cap (Mar-08-2026)
0.16
Employee Count
442
Employee Count as of Date
As on 2021
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
209 Million USD
Annual Net Income in USD
-124 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
305 Million USD
Total Liabilities in USD
384 Million USD
Total Equity in USD
-79 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector

Share

Ads